Answers are grounded in this paper and cite their sources.
We report a patient who developed exercise-induced anaphylaxis after starting the dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonist tirzepatide, who after discontinuing tirzepatide, experienced resolution of exercise-induced anaphylaxis.
No takes yet. Share an insight, caveat, or question.
Chong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: